Data: Cancer.gov; Map: Axios Visuals Colorectal cancer is now the deadliest cancer for Americans under 50, per new JAMA research — and cases are rising in Georgia. Why it matters: Screening more young ...
The oral molecular glue degrader aims to overcome resistance to standard ALK tyrosine kinase inhibitor therapies.
TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused on advancing a target-first and proximity-first molecular glue discovery platform to address difficult to drug disease ...
The 2026 IASLC Targeted Therapies in Lung Cancer meeting brought together leading oncologists, surgeons, and patient ...
TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. (ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT ...
A research team in the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has conducted a pioneering study that found an association ...
A cancer diagnosis is never welcome news. But for certain types of cancers, a doctor’s confirmation can be a lifesaver. That’s especially true with colorectal—or colon—cancer (CRC): When caught early, ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global immuno-oncology market is set to explode from ...
A recent study in Nature Communications suggests that Americans living closer to nuclear power plants face higher cancer ...
A large CT imaging study identifies many clues which are the key risk factors linked to fast-growing lung cancer, supporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results